|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-12-23
|
|
pubmed:abstractText |
Cancer immunotherapy is a conceptually attractive since it is highly specific and can deal with disseminated disease with minimal impact on normal tissues. Early phase clinical trials have well established the ability of a variety of immunotherapeutic approaches to induce antigen specific immune responses in lung cancer patients. Although no immunotherapy is likely to be a panacea, recent data from randomized phase IIB studies offer promise of therapeutic activity in both early and late stage lung cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
169-73
|
|
pubmed:meshHeading |
pubmed-meshheading:21150468-Adenocarcinoma,
pubmed-meshheading:21150468-Aged,
pubmed-meshheading:21150468-Aged, 80 and over,
pubmed-meshheading:21150468-Cancer Vaccines,
pubmed-meshheading:21150468-Carcinoma, Large Cell,
pubmed-meshheading:21150468-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:21150468-Carcinoma, Squamous Cell,
pubmed-meshheading:21150468-Female,
pubmed-meshheading:21150468-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:21150468-Humans,
pubmed-meshheading:21150468-Immunotherapy,
pubmed-meshheading:21150468-Lung Neoplasms,
pubmed-meshheading:21150468-Male,
pubmed-meshheading:21150468-Middle Aged,
pubmed-meshheading:21150468-Neoplasm Staging,
pubmed-meshheading:21150468-Pilot Projects,
pubmed-meshheading:21150468-Prospective Studies,
pubmed-meshheading:21150468-Survival Rate,
pubmed-meshheading:21150468-Treatment Outcome,
pubmed-meshheading:21150468-Vaccination
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Pilot study of 1650-G: a simplified cellular vaccine for lung cancer.
|
|
pubmed:affiliation |
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Kentucky Chandler Medical Center, Lexington, KY 40536-0298, USA. eahirs2@uky.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
